Pashupati Chemicals & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-12-2024
- Paid Up Capital ₹ 2.37 M
as on 15-12-2024
- Company Age 40 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.99 M
as on 15-12-2024
- Revenue -2.07%
(FY 2020)
- Profit -69.11%
(FY 2020)
- Ebitda 13.26%
(FY 2020)
- Net Worth 2.36%
(FY 2020)
- Total Assets -2.09%
(FY 2020)
About Pashupati Chemicals & Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.37 M.
The company currently has active open charges totaling ₹5.99 M.
Murari Murarka, Rita Murarka, and Radheshyam Saha serve as directors at the Company.
- CIN/LLPIN
U67120WB1984PLC037410
- Company No.
037410
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Apr 1984
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pashupati Chemicals & Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murari Murarka  | Director | 02-May-1997 | Current |
| Rita Murarka | Director | 28-Apr-2018 | Current |
| Radheshyam Saha | Director | 25-Jul-2018 | Current |
Financial Performance of Pashupati Chemicals & Pharmaceuticals.
Pashupati Chemicals & Pharmaceuticals Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.07% decrease. The company also saw a substantial fall in profitability, with a 69.11% decrease in profit. The company's net worth moved up by a moderate rise of 2.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pashupati Chemicals & Pharmaceuticals?
In 2019, Pashupati Chemicals & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Psl Financial Services Ltd.Active 35 years 11 monthsMurari Murarka and Rita Murarka are mutual person
- Phyto Medicines Ltd.Active 35 years 8 months
Murari Murarka, Rita Murarka and 1 more are mutual person
- Saffy Healthcare Private LimitedActive 36 years 5 months
Murari Murarka and Rita Murarka are mutual person
- Pashupati Promoters LimitedActive 35 years 4 months
Murari Murarka, Rita Murarka and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jun 2020 | ₹0.38 M | Open |
Others Creation Date: 30 Nov 2018 | ₹0.75 M | Open |
Others Creation Date: 26 Jul 1993 | ₹4.86 M | Open |
How Many Employees Work at Pashupati Chemicals & Pharmaceuticals?
Unlock and access historical data on people associated with Pashupati Chemicals & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pashupati Chemicals & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pashupati Chemicals & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
